about
Cancer Bioinformatic Methods to Infer Meaningful Data From Small-Size CohortsCirculating tumor cells isolation: the "post-EpCAM era"Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasisTumour Heterogeneity: The Key Advantages of Single-Cell AnalysisProgress in the clinical detection of heterogeneity in breast cancerHigh efficiency vortex trapping of circulating tumor cells.Metabolic history impacts mammary tumor epithelial hierarchy and early drug response in mice.On a fractional order calculus model in diffusion weighted breast imaging to differentiate between malignant and benign breast lesions detected on X-ray screening mammography.Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.Molecular characterization of breast cancer cell lines by clinical immunohistochemical markers.Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodesPrimary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases.Endocrine resistance in breast cancer--An overview and update.Developmental Insights into Breast Cancer Intratumoral Heterogeneity.miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.Classical pathology and mutational load of breast cancer - integration of two worlds.Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET.Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer.Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer.Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer.Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer.Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas.Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.Overview of Transgenic Glioblastoma and Oligoastrocytoma CNS Models and Their Utility in Drug DiscoveryHexamethylene amiloride engages a novel reactive oxygen species- and lysosome-dependent programmed necrotic mechanism to selectively target breast cancer cells.Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers.Breast cancer stem cell: the roles and therapeutic implications.Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways.Patient-derived xenograft (PDX) models in basic and translational breast cancer research.Oncolytic viruses: emerging options for the treatment of breast cancer.Breast cancer in young women: an overview.T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumors.Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.Molecular characterization of CD44+/CD24-/Ck+/CD45- cells in benign and malignant breast lesions.Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutationsRor2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression.
P2860
Q26777117-B0FF1539-0BAF-4873-8EF3-6E1C1C186334Q26778917-569E127F-2C01-4D23-9695-5219E6DBBA26Q26991480-05D6DB9A-0B3F-4311-8AF2-7A362DF5D30AQ28066914-AD7969F0-5FB6-4654-B745-22BCC3CB47A4Q28079224-932BACD4-1B41-4C90-BA19-2A6D5C4ECBEAQ30367788-094F4DD3-9627-4DC7-8BAD-9CC367130EABQ30390384-64DF3EC4-D457-4C56-8FE1-8E288BD74698Q33615009-EEC6D65B-3EFF-440C-B493-E794629DC16CQ33681837-B4D54549-1E7F-4015-A5F4-89B6BFB68B72Q33750808-5523C8C4-0079-4676-A79A-A217C91D8E2DQ33913936-A841FDAB-12CD-4D6F-8A43-CC985CF3D1B4Q36137401-7E1DD4BF-D51C-4245-B744-380604657B04Q36386322-A3FD4CB0-D744-4FBC-B2F6-719E379E5AC9Q36438839-FD3EC9A6-9963-4824-933F-3B4F92F8EF3CQ36666943-8066E520-9D00-423E-ADDB-64CE438891FFQ37082568-B39DA0BD-7120-4CCE-BB26-5065B928356CQ37112967-1F60B3DF-FE38-4747-A31C-7A5820D4B3C1Q37134529-A319A91A-FA49-4C05-A21E-F8A0D2EAFA1EQ37175888-92DEEA9D-126E-41D0-B307-50878DF0D982Q37479076-013D7FD1-B092-41AE-97B9-A2D777319EA9Q37648136-E83FD8A8-484B-43D5-A042-3D91A253CACEQ37665209-C1976F59-448F-41F3-ABA3-D2C95AADBC8CQ38390966-7FD0F08E-DB47-4BBF-A15E-ABCABEF25B9BQ38649987-506EFB75-9B25-4E70-BD90-93BB0619F214Q38679084-DE3C8CCF-0FEB-44D4-9AA6-07B065657F9BQ38781953-168EDB3A-2E80-431F-8211-B6B9AB2B4A28Q38788869-CAF5F960-CE8A-49A2-9A98-BFF5DE1EF2DFQ38819847-1F436536-0DAF-48B8-92A3-333C8FE762A9Q38929036-3970C5CA-F27D-4CDA-9C70-A5094B3974FBQ39017596-67A88C6D-256A-4CC4-88B1-BFBC54A027BEQ39028398-272211F9-4281-4D7A-B168-CE4BF6C1546CQ39057246-7BC96E85-2A77-44C2-BD57-A93AFCE9983EQ39129326-0718D485-B928-4E7E-B991-63582B4D5129Q39161921-5EB4AF5E-2D2A-432B-8582-F039C331D2F5Q39499897-21D11125-9AE8-44EC-97A3-8E899CED5959Q40062750-095B68C5-D836-40BC-AC08-D826D88D2E58Q40367258-FD713D63-4117-43BA-BC49-C3F77ADE9358Q41276800-F1E73D3A-AA00-4118-8A1E-26529A158FCFQ41833215-795DCBB6-81CD-4C30-AA02-0288EDAB0767Q42511518-0ED2A5F7-D2B1-4907-AA90-CFB8DFBAB2FE
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Breast cancer intra-tumor heterogeneity
@ast
Breast cancer intra-tumor heterogeneity
@en
Breast cancer intra-tumor heterogeneity
@nl
type
label
Breast cancer intra-tumor heterogeneity
@ast
Breast cancer intra-tumor heterogeneity
@en
Breast cancer intra-tumor heterogeneity
@nl
prefLabel
Breast cancer intra-tumor heterogeneity
@ast
Breast cancer intra-tumor heterogeneity
@en
Breast cancer intra-tumor heterogeneity
@nl
P2860
P50
P921
P3181
P356
P1476
Breast cancer intra-tumor heterogeneity
@en
P2093
Charlotte KY Ng
Luciano G Martelotto
P2860
P2888
P3181
P356
10.1186/BCR3658
P407
P5008
P577
2014-05-20T00:00:00Z
P5875
P6179
1043424385